eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | chronic myeloproliferative disease |
| Comorbidity | C0002871|anemia |
| Sentences | 3 |
| PubMedID- 20538336 | Does auto-immunity contribute to anemia in myeloproliferative neoplasms (mpn)-associated myelofibrosis. |
| PubMedID- 20973233 | In bm imprint group, the diagnostic accuracy for hypersplenism (n = 130), metastatic carcinoma (n = 67), refractory anemia with excess blasts, myeloproliferative neoplasm (n = 174), and pcm (n = 94) were better than smear group (96.9% vs 80.7%, 91.0% vs 76.1%, 92.6% vs 81.5%, 92.5% vs 76.4%, and 97.8% vs 92.6% respectively, all p < 0.05); and the diagnostic accuracy for megaloblastic anemia (n = 69), acute myeloid leukemia (n = 104), refractory cytopenia with unilineage dysplasia (n = 15), refractory cytopenia with multilineage dysplasia (n = 22), and lymphoplasmacytic lymphoma (n = 12) were higher than biopsy section group (100% vs 84.0%, 91.3% vs 74.0%, 86.7% vs 60.0%, 90. |
| PubMedID- 24636526 | Use of the functional assessment of cancer therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia. |
Page: 1